/Stocks/KVUE
▲ Cast your call
KVUEKenvue Inc. · NYSE · Consumer Defensive
$17.53+$0.07 · +0.40%
MKT 33.72B

Company Overview

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Sector
Consumer Defensive
Industry
Household & Personal Products
Phone
908 874 1200
Headquarters
1 Kenvue Way
Summit, NJ, 07901
United States
Full-Time Employees
21,780

Key Metrics

P/E Ratio (TTM)
20.90
Forward P/E
14.26
Price to Book
3.13
Beta
0.52
Profit Margin
10.61%
Gross Margin
58.60%
Return on Equity
15.70%
Return on Assets
7.07%
Earnings Growth
46.90%
Revenue Growth
4.50%
Dividend Yield
475.00%
Dividend Rate
$0.83

Financial Health

Total Cash
$1.08B
Total Debt
$8.80B
Debt to Equity
82.98
Current Ratio
0.98
Free Cash Flow
$1.86B
Operating Cash Flow
$2.26B

Analyst Recommendations

Target Price (Mean)
$19.27
Target High
$23.00
Target Low
$18.00
Recommendation
hold
Analyst Coverage
11 Analysts

Trading Ideas

Related Stocks

Will KVUE Beat Earnings? AI Prediction next earnings | CallTheBeat